Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects
Clinical trial NCT01068756 · TERMINATED
Trial details
- NCT number
- NCT01068756
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2010-04-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.